Clinic Mont Louis
Clinic Mont Louis
Frankreich, Paris
| Frankreich | Türkei | Österreich | |
| Weite Exzision | von $8,500 | von $2,700 | von $8,500 |
| Tomotherapie | von $35,000 | von $12,000 | von $30,000 |
| Strahlentherapie bei Darmkrebs | von $18,000 | von $7,000 | von $12,000 |
| Strahlentherapie bei Brustkrebs | von $9,000 | von $4,500 | von $10,000 |
| Protonentherapie bei Brustkrebs | von $75,000 | von $30,000 | von $55,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Brustkrebs-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Brustkrebs einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Brustkrebs-Behandlungsreise nie allein.
Geschrieben von Anna Leonova
Geschrieben von Anna Leonova
International patients in France are not automatically covered for oncology treatments. Full coverage is only available to legal residents registered with the French Social Security system (PUMA). Non-residents traveling specifically for medical care must pay out-of-pocket or use private international insurance.
Bookimed Expert Insight: While public systems have strict residency rules, private multidisciplinary hospitals like Clinic Mont Louis in Paris offer high-volume expertise. This facility performs 20,000 surgeries annually with 120 specialists. Seeking treatment at such centers often avoids the 3-month waiting period required for French state insurance registration.
Patient Consensus: Patients note that without residency, costs for surgery and chemotherapy are high. Many recommend securing comprehensive private insurance like Allianz or Cigna before starting treatment to cover the 20-30% gap left after standard French reimbursement rates.
France offers elite breast cancer care through the Unicancer network of specialized centers. Gustave Roussy and Institut Curie are global leaders in oncology. These facilities provide advanced treatments like immunotherapy and precision medicine. They maintain high success rates for complex and metastatic cases through multidisciplinary tumor boards.
Bookimed Expert Insight: Paris centers like Gustave Roussy often have the longest wait times for initial consultations. Regional academic centers in Lyon or Dijon provide the same high-level multidisciplinary reviews. Choosing a top-tier regional hospital can often accelerate your treatment start by several weeks. This timing is vital for aggressive or advanced stage cases.
Patient Consensus: Patients note that French centers prioritize breast-conserving surgery and immediate reconstruction as standard care. While the language barrier exists, many suggest having a French-speaking advocate to navigate the collegial review process faster.
French surgical teams routinely perform breast-conserving procedures in 75% of cases. Advanced methods include level 1 and 2 oncoplastic surgery to preserve breast shape. Specialized centers utilize robot-assisted nipple-sparing mastectomies. These techniques prioritize oncological safety while maintaining natural aesthetic outcomes during tumor removal.
Bookimed Expert Insight: While many European centers offer standard lumpectomies, French hospitals like Clinic Mont Louis in Paris leverage high surgical volumes to refine aesthetic outcomes. With 20,000 surgeries performed annually at such facilities, surgeons frequently utilize oncoplastic reduction. This ensures the breast is reshaped during the initial cancer removal rather than in a secondary procedure.
Patient Consensus: Patients emphasize that surgeons in France are often dual-trained in oncology and plastic surgery. They recommend choosing high-volume breast units to ensure access to advanced flap reconstructions and nipple-sparing techniques.
Breast cancer treatment in France typically begins within 7 to 28 days following a formal diagnosis. Rapid pathways mandated by national cancer plans prioritize aggressive cases for systemic therapy within one week. Early-stage surgical interventions usually occur between two and four weeks after diagnostic confirmation.
Bookimed Expert Insight: Patient volume at major French centers significantly impacts your treatment start date. Facilities like Clinic Mont Louis in Paris handle 45,000 annual consultations and 20,000 surgeries. This high capacity often allows urban hospitals to schedule procedures within 14 days. This is notably faster than the 42-day average seen in smaller regional facilities.
Patient Consensus: Patients note that confirming the RCP date immediately after a biopsy is essential for speed. Many describe starting neo-adjuvant chemotherapy in under five days when biopsies indicate aggressive tumor markers.
Patients in France act as active partners in breast cancer treatment through shared decision-making. You contribute personal values and goals to reach a clinical consensus. French law guarantees your right to informed consent. You may also refuse specific interventions like breast reconstruction surgery or non-essential procedures.
Bookimed Expert Insight: French oncology centers like Clinic Mont Louis manage high volumes with over 20,000 surgeries annually. This scale allows for personalized care protocols where patients can request therapeutic vacations. These short pauses in treatment help manage mental health without compromising the primary medical strategy. Always discuss these breaks during your initial consultation with an oncologist in Paris.
Patient Consensus: Patients note they can effectively advocate for breast preservation under the personalized care system. Many suggest using advocacy templates from local associations to clearly communicate quality-of-life preferences to the surgical team.